HIV reservoirs: pathogenesis and obstacles to viral eradication and cure
- PMID: 22472858
- DOI: 10.1097/QAD.0b013e328353f3f1
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure
Abstract
Plasma HIV viremia can be suppressed and maintained below the limits of detection for prolonged periods of time in the vast majority of HIV-infected individuals who receive antiretroviral therapy (ART). Thus, the clinical outcome for HIV-infected individuals who have access to these drugs is dramatically improved. However, ART alone cannot eradicate HIV in infected individuals and this impediment is likely in part due to the persistence of viral reservoirs in the peripheral blood and lymphoid tissues of infected individuals despite the suppression of plasma viremia. In recent years, major research efforts have been dedicated to a better understanding of the pathogenesis of persistent HIV infection and to the development of therapeutic strategies aimed at eradicating virus in infected individuals receiving ART. In this review, we discuss the pathophysiology of CD4 T-cell HIV reservoirs, including recent advances in our understanding of the mechanisms of persistent viral infection and perspectives for eradication of HIV in infected individuals.
Similar articles
-
CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy.J Clin Virol. 2012 Jan;53(1):29-32. doi: 10.1016/j.jcv.2011.09.018. Epub 2011 Oct 22. J Clin Virol. 2012. PMID: 22019250
-
Tracking replication-competent HIV reservoirs in infected individuals.Curr Opin HIV AIDS. 2013 Mar;8(2):111-6. doi: 10.1097/COH.0b013e32835d6e1c. Curr Opin HIV AIDS. 2013. PMID: 23380652 Review.
-
Can HIV infection be eradicated through use of potent antiviral agents?Curr Opin Infect Dis. 2010 Dec;23(6):628-32. doi: 10.1097/QCO.0b013e32833ff1d0. Curr Opin Infect Dis. 2010. PMID: 20847693 Review.
-
The search for a cure for persistent HIV reservoirs.AIDS Rev. 2011 Apr-Jun;13(2):63-6. AIDS Rev. 2011. PMID: 21587339 Review.
-
HIV reservoirs, latency, and reactivation: prospects for eradication.Antiviral Res. 2010 Jan;85(1):286-94. doi: 10.1016/j.antiviral.2009.09.016. Epub 2009 Oct 4. Antiviral Res. 2010. PMID: 19808057 Review.
Cited by
-
Roadblocks to translational challenges on viral pathogenesis.Nat Med. 2013 Jan;19(1):30-4. doi: 10.1038/nm.3050. Nat Med. 2013. PMID: 23296014 Free PMC article.
-
Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses.J Virol. 2013 Sep;87(17):9620-32. doi: 10.1128/JVI.01165-13. Epub 2013 Jun 26. J Virol. 2013. PMID: 23804632 Free PMC article.
-
Genotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013.PLoS One. 2014 Oct 15;9(10):e109821. doi: 10.1371/journal.pone.0109821. eCollection 2014. PLoS One. 2014. PMID: 25333965 Free PMC article.
-
Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir.Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13151-6. doi: 10.1073/pnas.1414148111. Epub 2014 Aug 25. Proc Natl Acad Sci U S A. 2014. PMID: 25157148 Free PMC article.
-
Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates.Front Immunol. 2017 Mar 23;8:314. doi: 10.3389/fimmu.2017.00314. eCollection 2017. Front Immunol. 2017. PMID: 28386256 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials